DE3650625T2
(de)
|
1985-01-28 |
1997-10-02 |
Xoma Corp |
AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
IN165717B
(ko)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
US6004781A
(en)
|
1988-01-22 |
1999-12-21 |
The General Hospital Corporation |
Nucleic acid encoding Ig-CD4 fusion proteins
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
IL86278A
(en)
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
US6406697B1
(en)
|
1989-02-23 |
2002-06-18 |
Genentech, Inc. |
Hybrid immunoglobulins
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
US5216132A
(en)
|
1990-01-12 |
1993-06-01 |
Protein Design Labs, Inc. |
Soluble t-cell antigen receptor chimeric antigens
|
US20020004052A1
(en)
|
1990-05-08 |
2002-01-10 |
David Berd |
Composition comprising a tumor cell extract and method of using the composition
|
US5914109A
(en)
|
1990-06-15 |
1999-06-22 |
New York University |
Heterohybridomas producing human monoclonal antibodies to HIV-1
|
DE69123241T2
(de)
|
1990-12-14 |
1997-04-17 |
Cell Genesys Inc |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
US20020111474A1
(en)
|
1990-12-14 |
2002-08-15 |
Capon Daniel J. |
Chimeric chains for receptor-associated signal transduction pathways
|
US6407221B1
(en)
|
1990-12-14 |
2002-06-18 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
IL101147A
(en)
|
1991-03-07 |
2004-06-20 |
Gen Hospital Corp |
Change of direction of cellular immunity by chimera receptors
|
EP0575537A1
(en)
|
1991-03-08 |
1993-12-29 |
Cytomed, Inc. |
Soluble cd28 proteins and methods of treatment therewith
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
CA2121487A1
(en)
|
1991-10-21 |
1993-04-29 |
Stephen A. Sherwin |
Combined cellular and immunosuppresive therapies
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
US5372930A
(en)
|
1992-09-16 |
1994-12-13 |
The United States Of America As Represented By The Secretary Of The Navy |
Sensor for ultra-low concentration molecular recognition
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
WO1994009820A1
(en)
|
1992-11-05 |
1994-05-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
CA2160011A1
(en)
|
1993-04-06 |
1994-10-13 |
Philip D. Greenberg |
Chimeric cytokine receptors in lymphocytes
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
US6051427A
(en)
|
1993-06-11 |
2000-04-18 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
US5525503A
(en)
|
1993-09-28 |
1996-06-11 |
Dana-Farber Cancer Institute, Inc. |
Signal transduction via CD28
|
US5935818A
(en)
|
1995-02-24 |
1999-08-10 |
Sloan-Kettering Institute For Cancer Research |
Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
|
DK0758394T3
(da)
|
1994-05-02 |
2003-03-03 |
Bernd Groner |
Bifunktionelt protein, fremstilling og anvendelse
|
US7354587B1
(en)
|
1994-07-06 |
2008-04-08 |
Immunomedics, Inc. |
Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
US5716614A
(en)
|
1994-08-05 |
1998-02-10 |
Molecular/Structural Biotechnologies, Inc. |
Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
|
WO1996013584A1
(en)
|
1994-11-01 |
1996-05-09 |
Targeted Genetics Corporation |
Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
|
US5741899A
(en)
|
1995-02-02 |
1998-04-21 |
Cell Genesys, Inc. |
Chimeric receptors comprising janus kinase for regulating cellular pro liferation
|
US5712149A
(en)
|
1995-02-03 |
1998-01-27 |
Cell Genesys, Inc. |
Chimeric receptor molecules for delivery of co-stimulatory signals
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
US7037647B1
(en)
|
1995-02-24 |
2006-05-02 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
WO1997034634A1
(en)
|
1996-03-20 |
1997-09-25 |
Sloan-Kettering Institute For Cancer Research |
Single chain fv constructs of anti-ganglioside gd2 antibodies
|
US6261787B1
(en)
|
1996-06-03 |
2001-07-17 |
Case Western Reserve University |
Bifunctional molecules for delivery of therapeutics
|
US5969102A
(en)
|
1997-03-03 |
1999-10-19 |
St. Jude Children's Research Hospital |
Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
|
US20020018783A1
(en)
|
1997-03-20 |
2002-02-14 |
Michel Sadelain |
Fusion proteins of a single chain antibody and cd28 and uses thereof
|
CA2293270A1
(en)
|
1997-06-11 |
1998-12-17 |
New York University |
Prenylcysteine carboxyl methyltransferase, dna encoding same, and a method of screening for inhibitors thereof
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US20090011984A1
(en)
|
1998-02-23 |
2009-01-08 |
Seppo Yla-Herttuala |
Biotin-binding receptor molecules
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
NZ507887A
(en)
|
1998-05-19 |
2002-12-20 |
Avidex Ltd |
Soluble T cell receptor
|
EP1109921A4
(en)
|
1998-09-04 |
2002-08-28 |
Sloan Kettering Inst Cancer |
FOR PROSTATE-SPECIFIC MEMBRANE-ANTI-SPECIFIC FUSION RECEPTORS AND THEIR USE
|
WO2000023573A2
(en)
|
1998-10-20 |
2000-04-27 |
City Of Hope |
Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
|
ATE370967T1
(de)
|
1998-10-21 |
2007-09-15 |
Altor Bioscience Corp |
Polyspezifische bindemoleküle und deren verwendung
|
US7217421B1
(en)
|
1998-11-03 |
2007-05-15 |
Cell Genesys, Inc. |
Cancer-associated antigens and methods of their identification and use
|
US6521602B1
(en)
|
1999-03-01 |
2003-02-18 |
Gpc Biotech Inc. |
Anti-neoplastic compositions and uses thereof
|
US7052906B1
(en)
|
1999-04-16 |
2006-05-30 |
Celltech R & D Limited |
Synthetic transmembrane components
|
US6699972B1
(en)
|
1999-06-25 |
2004-03-02 |
Academia Sinica |
Chimeric protein and method of controlling tumor growth using the protein
|
EP1248645B1
(en)
|
2000-01-03 |
2007-04-18 |
Tr Associates, L.L.C. |
Novel chimeric proteins and their use
|
AU2001236967A1
(en)
|
2000-02-14 |
2001-08-27 |
The Regents Of The University Of California |
Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
|
US6770749B2
(en)
|
2000-02-22 |
2004-08-03 |
City Of Hope |
P53-specific T cell receptor for adoptive immunotherapy
|
CZ304942B6
(cs)
|
2000-03-31 |
2015-02-04 |
Purdue Research Foundation |
Léčivo pro zvyšování specifické eliminace populace tumorových buněk a farmaceutický prostředek obsahující konjugát fosfát-FITC nebo fosfát-dinitrofenyl
|
WO2001091625A2
(en)
|
2000-04-21 |
2001-12-06 |
Rutgers, The State University Of New Jersey |
Methods and compositions for the diagnosis of schizophrenia
|
US6524572B1
(en)
|
2000-06-26 |
2003-02-25 |
Rainbow Therapeutic Company |
Targeting recombinant virus with a bispecific fusion protein ligand in coupling with an antibody to cells for gene therapy
|
WO2002010369A1
(fr)
|
2000-07-31 |
2002-02-07 |
Kyogo Itoh |
Antigene associe aux tumeurs
|
US7666424B2
(en)
|
2001-10-17 |
2010-02-23 |
Sloan-Kettering Institute For Cancer Research |
Methods of preparing and using single chain anti-tumor antibodies
|
CA2425862C
(en)
|
2000-11-07 |
2013-01-22 |
City Of Hope |
Cd19-specific redirected immune cells
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
US20030171546A1
(en)
|
2001-04-30 |
2003-09-11 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
WO2004016643A2
(en)
|
2002-08-16 |
2004-02-26 |
Yeda Research And Development Co. Ltd. |
Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
|
WO2004021861A2
(en)
|
2002-09-03 |
2004-03-18 |
Vit Lauermann |
Targeted release
|
DE10244457A1
(de)
|
2002-09-24 |
2004-04-01 |
Johannes-Gutenberg-Universität Mainz |
Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
US20060018878A1
(en)
|
2003-03-11 |
2006-01-26 |
City Of Hope |
Dual antigen specific T cells with trafficking ability
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
US20050113564A1
(en)
|
2003-11-05 |
2005-05-26 |
St. Jude Children's Research Hospital |
Chimeric receptors with 4-1BB stimulatory signaling domain
|
US8652484B2
(en)
|
2004-02-13 |
2014-02-18 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
WO2005079836A1
(en)
|
2004-02-18 |
2005-09-01 |
Wisconsin Alumni Research Foundation |
Method for treating glaucoma
|
WO2005084716A2
(en)
|
2004-03-02 |
2005-09-15 |
Cellectar, Llc |
Phospholipid analogs for diagnosis and treatment of cancer
|
CA3052445C
(en)
|
2004-07-10 |
2023-08-22 |
Kerry S. Campbell |
Genetically modified human natural killer cell lines
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
WO2006036445A2
(en)
|
2004-09-24 |
2006-04-06 |
Trustees Of Dartmouth College |
Chimeric nk receptor and methods for treating cancer
|
US7998736B2
(en)
|
2004-10-08 |
2011-08-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy with enhanced T lymphocyte survival
|
AU2005335714B2
(en)
|
2004-11-10 |
2012-07-26 |
Macrogenics, Inc. |
Engineering Fc antibody regions to confer effector function
|
WO2007044033A2
(en)
|
2004-12-07 |
2007-04-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
|
US20070036773A1
(en)
|
2005-08-09 |
2007-02-15 |
City Of Hope |
Generation and application of universal T cells for B-ALL
|
EP1979379B1
(en)
|
2005-12-02 |
2013-09-18 |
Dana-Farber Cancer Institute |
Carbonic anhydrase ix (g250) antibodies and methods of use thereof
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
MX2008015524A
(es)
|
2006-06-12 |
2009-01-13 |
Trubion Pharmaceuticals Inc |
Proteinas de union multivalentes monocatenarias con funcion efectora.
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
US20100105136A1
(en)
|
2006-10-09 |
2010-04-29 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
US9334330B2
(en)
|
2006-10-10 |
2016-05-10 |
Universite De Nantes |
Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers
|
CA2668197A1
(en)
|
2006-11-03 |
2008-05-15 |
Philip S. Low |
Ex vivo flow cytometry method and device
|
JP5188504B2
(ja)
|
2006-11-13 |
2013-04-24 |
サンガモ バイオサイエンシズ インコーポレイテッド |
ヒトグルココルチコイド受容体遺伝子座の修飾のための方法および組成物
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
US8748405B2
(en)
|
2007-01-26 |
2014-06-10 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
WO2008093688A1
(ja)
|
2007-01-30 |
2008-08-07 |
Forerunner Pharma Research Co., Ltd. |
キメラFcγレセプター及び該レセプターを用いたADCC活性測定方法
|
WO2008095141A2
(en)
|
2007-01-31 |
2008-08-07 |
Yeda Research And Development Co. Ltd. |
Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
US8865169B2
(en)
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
EP3357338A1
(en)
|
2007-03-30 |
2018-08-08 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes
|
WO2009020093A1
(ja)
|
2007-08-09 |
2009-02-12 |
Daiichi Sankyo Company, Limited |
デスドメイン含有受容体発現細胞にアポトーシスを誘導するイムノリポソーム
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
US20110070191A1
(en)
|
2008-03-19 |
2011-03-24 |
Wong Hing C |
T cell receptor fusions and conjugates and methods of use there of
|
DK2279253T3
(en)
|
2008-04-09 |
2017-02-13 |
Maxcyte Inc |
Construction and application of therapeutic compositions of freshly isolated cells
|
WO2009126944A1
(en)
|
2008-04-11 |
2009-10-15 |
Trubion Pharmaceuticals, Inc. |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
US20090324630A1
(en)
|
2008-04-21 |
2009-12-31 |
Jensen Michael C |
Fusion multiviral chimeric antigen
|
EP2331566B1
(en)
|
2008-08-26 |
2015-10-07 |
City of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
NZ592255A
(en)
|
2008-09-17 |
2013-07-26 |
Endocyte Inc |
Folate receptor binding conjugates of antifolates
|
CN104195227B
(zh)
|
2008-11-07 |
2017-04-12 |
适应生物技术公司 |
通过序列分析监测状况的方法
|
EP3936122A1
(en)
|
2008-11-24 |
2022-01-12 |
Massachusetts Institute Of Technology |
Methods and compositions for localized agent delivery
|
US20110178279A1
(en)
|
2009-08-03 |
2011-07-21 |
Williams John C |
Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodies
|
US8877199B2
(en)
|
2009-05-15 |
2014-11-04 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
B cell surface reactive antibodies
|
US20100322909A1
(en)
|
2009-06-17 |
2010-12-23 |
The University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Th1-associated micrornas and their use for tumor immunotherapy
|
JP5934099B2
(ja)
|
2009-10-01 |
2016-06-15 |
アメリカ合衆国 |
抗血管内皮増殖因子受容体−2キメラ抗原受容体及び癌の治療のためのその使用
|
US9211321B2
(en)
|
2009-10-27 |
2015-12-15 |
Immunicum Ab |
Method for proliferation of antigen-specific T cells
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
CA2779526C
(en)
|
2009-11-03 |
2022-12-06 |
City Of Hope |
Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
CA2783550A1
(en)
|
2009-12-08 |
2011-06-16 |
Wilson Wolf Manufacturing Corporation |
Improved methods of cell culture for adoptive cell therapy
|
IN2012DN06629A
(ko)
|
2010-01-28 |
2015-10-23 |
Philadelphia Children Hospital |
|
WO2011097477A1
(en)
|
2010-02-04 |
2011-08-11 |
The Trustees Of The University Of Pennsylvania |
Icos critically regulates the expansion and function of inflammatory human th17 cells
|
JP6034696B2
(ja)
|
2010-02-12 |
2016-11-30 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ポリペプチド発現細胞の同定及び単離の方法
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
WO2011130491A2
(en)
|
2010-04-14 |
2011-10-20 |
Roger Williams Medical Center |
Methods and compositions for treating hiv
|
EP2566954B2
(en)
|
2010-05-04 |
2022-11-02 |
Yeda Research and Development Co. Ltd. |
Immunotherapy using redirected allogeneic cells
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
WO2011159847A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
|
WO2012012695A2
(en)
|
2010-07-23 |
2012-01-26 |
Fred Hutchinson Cancer Research Center |
A method for the treatment of obesity
|
DE102010036122A1
(de)
|
2010-09-01 |
2012-03-01 |
Nora Systems Gmbh |
Bodenbelag
|
US9487800B2
(en)
|
2010-09-08 |
2016-11-08 |
Chemotherapeutisches Forschunginstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
EP3012268B1
(en)
|
2010-09-08 |
2017-11-15 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Chimeric antigen receptors with an optimized hinge region
|
WO2012033885A1
(en)
|
2010-09-08 |
2012-03-15 |
Baylor College Of Medicine |
Immunotherapy of cancer using genetically engineered gd2-specific t cells
|
CN103124740B
(zh)
|
2010-09-21 |
2015-09-02 |
美国卫生和人力服务部 |
抗-ssx-2t细胞受体和相关材料及使用方法
|
EP2619313B1
(en)
|
2010-09-26 |
2021-11-10 |
Da Yu Enterprises, L.L.C. |
Method of recombinant macromolecular production
|
US9845362B2
(en)
|
2010-10-08 |
2017-12-19 |
The University Of North Carolina At Charlotte |
Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
|
WO2012054825A1
(en)
|
2010-10-22 |
2012-04-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mage-a3 t cell receptors and related materials and methods of use
|
BR122021026169B1
(pt)
|
2010-12-09 |
2023-12-12 |
The Trustees Of The University Of Pennsylvania |
Uso de uma célula
|
WO2012076059A1
(en)
|
2010-12-09 |
2012-06-14 |
Stichting Het Nederlands Kanker Instituut |
Immune restricted peptides with increased efficacy
|
CA3102782A1
(en)
|
2010-12-14 |
2012-06-21 |
University Of Maryland, Baltimore |
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
|
AU2012207356A1
(en)
|
2011-01-18 |
2013-08-01 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating cancer
|
US9040669B2
(en)
|
2011-02-11 |
2015-05-26 |
Memorial Sloan Kettering Cancer Center |
HLA-restricted, peptide-specific antigen binding proteins
|
AU2012230780B2
(en)
|
2011-03-23 |
2016-10-27 |
Fred Hutchinson Cancer Center |
Method and compositions for cellular immunotherapy
|
EP2502934B1
(en)
|
2011-03-24 |
2018-01-17 |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
|
AU2012236068A1
(en)
|
2011-04-01 |
2013-10-17 |
Eureka Therapeutics, Inc. |
T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2
|
IL285335B2
(en)
|
2011-04-08 |
2023-12-01 |
Us Health |
Chimeric antigen receptors against epidermal growth factor receptor variant III and their use in cancer treatment
|
JP2014511704A
(ja)
|
2011-04-13 |
2014-05-19 |
イミュニカム・エイビイ |
T細胞のプライミングのための方法
|
WO2012140130A1
(en)
|
2011-04-13 |
2012-10-18 |
Immunicum Ab |
Method for proliferation of antigen-specific t cells
|
EP3070104B1
(en)
|
2011-04-19 |
2017-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
GB201108236D0
(en)
|
2011-05-17 |
2011-06-29 |
Ucl Business Plc |
Method
|
EP2736540B1
(en)
|
2011-07-29 |
2019-03-13 |
The Trustees Of The University Of Pennsylvania |
Switch costimulatory receptors
|
CN107586340B
(zh)
|
2011-08-23 |
2022-01-21 |
罗切格利卡特公司 |
对t细胞活化性抗原和肿瘤抗原特异性的双特异性抗体及使用方法
|
WO2013033626A2
(en)
|
2011-08-31 |
2013-03-07 |
Trustees Of Dartmouth College |
Nkp30 receptor targeted therapeutics
|
IL290105B2
(en)
|
2011-09-15 |
2024-04-01 |
Us Health |
MAGE-recognizing T cell receptors are restricted to 1HLA–A or HLA–CW7
|
EP2755487B1
(en)
|
2011-09-16 |
2018-12-19 |
Baylor College Of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
KR20140060541A
(ko)
|
2011-09-16 |
2014-05-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암을 치료하기 위한 rna 조작된 t 세포
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
KR101956751B1
(ko)
|
2011-10-07 |
2019-03-11 |
고쿠리츠다이가쿠호진 미에다이가쿠 |
키메라 항원 수용체
|
IN2014CN02906A
(ko)
|
2011-10-20 |
2015-07-03 |
Us Health |
|
KR101471647B1
(ko)
|
2011-10-26 |
2014-12-11 |
국립암센터 |
변이 ctla4 유전자 이입 t 세포 및 이를 포함하는 항암 면역치료용 조성물
|
WO2013063019A1
(en)
|
2011-10-28 |
2013-05-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
ES2861435T3
(es)
|
2011-11-03 |
2021-10-06 |
Univ Pennsylvania |
Composiciones específicas de B7-H4 aisladas y métodos de uso de las mismas
|
WO2013070468A1
(en)
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
KR102134932B1
(ko)
|
2011-11-11 |
2020-07-17 |
프레드 헛친슨 켄서 리서치 센터 |
암을 위한 사이클린 a1―표적화된 t―세포 면역요법
|
WO2013088446A1
(en)
|
2011-12-16 |
2013-06-20 |
Targetgene Biotechnologies Ltd |
Compositions and methods for modifying a predetermined target nucleic acid sequence
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
JP2015506372A
(ja)
|
2012-01-27 |
2015-03-02 |
グリックニック インコーポレイテッド |
IgG2ヒンジドメインを含む融合タンパク質
|
EP2814846B1
(en)
|
2012-02-13 |
2020-01-08 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
CN104136458A
(zh)
|
2012-02-22 |
2014-11-05 |
宾夕法尼亚大学董事会 |
在第二代嵌合抗原受体中cd2信号传导结构域的使用
|
US9714278B2
(en)
|
2012-02-22 |
2017-07-25 |
The Trustees Of The University Of Pennsylvania |
Use of ICOS-based CARs to enhance antitumor activity and CAR persistence
|
CA3209571A1
(en)
|
2012-03-23 |
2013-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
EP2836239A1
(en)
|
2012-04-11 |
2015-02-18 |
The United States of America, as Represented By the Secretary, Department of Health and Human Services |
Chimeric antigen receptors targeting b-cell maturation antigen
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
CN104395462B
(zh)
|
2012-05-03 |
2017-09-26 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
CN110511278A
(zh)
|
2012-05-07 |
2019-11-29 |
达特茅斯大学理事会 |
抗b7-h6抗体、融合蛋白及其使用方法
|
US8952169B2
(en)
|
2012-05-22 |
2015-02-10 |
Xenon Pharmaceuticals Inc. |
N-substituted benzamides and methods of use thereof
|
EP3828197A1
(en)
|
2012-05-22 |
2021-06-02 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Pharmaceutical composition comprising host cells encoding anti-ny-eso-1 t cell receptors
|
WO2013176916A1
(en)
|
2012-05-25 |
2013-11-28 |
Roman Galetto |
Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
|
US9409994B2
(en)
|
2012-06-01 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
CN104662153A
(zh)
|
2012-06-08 |
2015-05-27 |
学校法人近畿大学 |
针对转运体的抗体及其用途
|
JP5863585B2
(ja)
|
2012-07-11 |
2016-02-16 |
三菱電機株式会社 |
大信号等価回路モデルを用いたトランジスタ特性計算装置
|
IN2014DN10889A
(ko)
|
2012-07-13 |
2015-09-11 |
Univ Pennsylvania |
|
KR20150029714A
(ko)
|
2012-07-13 |
2015-03-18 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
이중특이적 항체의 공-도입에 의한 car 세포의 활성 증강
|
JP6482461B2
(ja)
|
2012-07-13 |
2019-03-13 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
投与に関する形質導入t細胞の適合性の評価方法
|
WO2014011984A1
(en)
|
2012-07-13 |
2014-01-16 |
The Trustees Of The University Of Pennsylvania |
Toxicity management for anti-tumor activity of cars
|
CN102775500A
(zh)
|
2012-08-03 |
2012-11-14 |
郑骏年 |
嵌合抗原受体iRGD-scFv(G250)-CD8-CD28-CD137-CD3ζ及其用途
|
RS61345B1
(sr)
|
2012-08-20 |
2021-02-26 |
Hutchinson Fred Cancer Res |
Postupak i kompozicije za ćelijsku imunoterapiju
|
US9409992B2
(en)
|
2012-08-21 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
KR102141259B1
(ko)
|
2012-09-04 |
2020-08-05 |
셀렉티스 |
멀티―체인 키메라 항원 수용체 및 그것의 용도들
|
JP6461796B2
(ja)
|
2012-09-14 |
2019-01-30 |
アメリカ合衆国 |
Mhcクラスii拘束性mage−a3を認識するt細胞受容体
|
WO2014052064A1
(en)
|
2012-09-27 |
2014-04-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
AR092745A1
(es)
|
2012-10-01 |
2015-04-29 |
Univ Pennsylvania |
Composiciones que comprenden un dominio de union anti-fap y metodos para hacer blanco en celulas estromales para el tratamiento del cancer
|
ES2743738T3
(es)
|
2012-10-02 |
2020-02-20 |
Memorial Sloan Kettering Cancer Center |
Composiciones y métodos para inmunoterapia
|
US9598489B2
(en)
|
2012-10-05 |
2017-03-21 |
The Trustees Of The Univeristy Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
WO2014055657A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
EP3763810A3
(en)
|
2012-10-10 |
2021-07-14 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
WO2014059248A1
(en)
|
2012-10-12 |
2014-04-17 |
Philadelphia Health & Education Corporation D/B/A/ Drexel |
Mir-155 enhancement of cd8+ t cell immunity
|
UY35103A
(es)
|
2012-10-29 |
2014-05-30 |
Glaxo Group Ltd |
Compuestos de cefem 2-sustituidos
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
US20150329640A1
(en)
|
2012-12-20 |
2015-11-19 |
Bluebird Bio, Inc. |
Chimeric antigen receptors and immune cells targeting b cell malignancies
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
SG11201505858VA
(en)
|
2013-01-28 |
2015-09-29 |
St Jude Childrens Res Hospital |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
AU2014214850C1
(en)
|
2013-02-06 |
2018-12-06 |
Celgene Corporation |
Modified T lymphocytes having improved specificity
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
CA2901115A1
(en)
|
2013-02-15 |
2014-08-21 |
The Regents Of The University Of California |
Heterodimeric conditionally active chimeric antigen receptor and methods of use thereof
|
WO2014130635A1
(en)
|
2013-02-20 |
2014-08-28 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
|
RU2708032C2
(ru)
|
2013-02-20 |
2019-12-03 |
Новартис Аг |
ЛЕЧЕНИЕ РАКА С ИСПОЛЬЗОВАНИЕМ ХИМЕРНОГО АНТИГЕНСПЕЦИФИЧЕСКОГО РЕЦЕПТОРА НА ОСНОВЕ ГУМАНИЗИРОВАННОГО АНТИТЕЛА ПРОТИВ EGFRvIII
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
US9402888B2
(en)
|
2013-03-14 |
2016-08-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for treating cancer
|
WO2014151960A2
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
US9587237B2
(en)
|
2013-03-14 |
2017-03-07 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
US9499855B2
(en)
|
2013-03-14 |
2016-11-22 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
US10351626B2
(en)
|
2013-03-14 |
2019-07-16 |
The Scripps Research Institute |
Targeting agent antibody conjugates and uses thereof
|
US9393268B2
(en)
|
2013-03-15 |
2016-07-19 |
Thomas Jefferson University |
Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
|
EP2970426B1
(en)
|
2013-03-15 |
2019-08-28 |
Michael C. Milone |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
US9446105B2
(en)
|
2013-03-15 |
2016-09-20 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor specific for folate receptor β
|
CN105518018B
(zh)
|
2013-03-15 |
2020-04-03 |
细胞基因公司 |
修饰的t淋巴细胞
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
US9561291B2
(en)
|
2013-03-15 |
2017-02-07 |
Imre Kovesdi |
Methods of targeting T-cells to tumors
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
KR102095700B1
(ko)
|
2013-05-14 |
2020-04-01 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
가공된 키메라 항원 수용체 (car) t-세포의 인간 적용
|
CN116083487A
(zh)
|
2013-05-15 |
2023-05-09 |
桑格摩生物治疗股份有限公司 |
用于治疗遗传病状的方法和组合物
|
EP3004168A4
(en)
|
2013-05-24 |
2017-03-01 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
WO2014191128A1
(en)
|
2013-05-29 |
2014-12-04 |
Cellectis |
Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
|
AU2014274916B2
(en)
|
2013-06-05 |
2019-10-31 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
US9738726B2
(en)
|
2013-06-11 |
2017-08-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HER2-specific monoclonal antibodies and conjugates thereof
|
CA2916245C
(en)
|
2013-06-25 |
2023-01-24 |
Vaccinex, Inc. |
Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases
|
US9808486B2
(en)
|
2013-08-30 |
2017-11-07 |
Board Of Regents, The University Of Texas System |
Administration of kynurenine depleting enzymes for tumor therapy
|
US20150073154A1
(en)
|
2013-09-11 |
2015-03-12 |
Equip, Llc |
Discrete PEG Based Dyes
|
ES2960807T3
(es)
|
2013-10-11 |
2024-03-06 |
Us Health |
Anticuerpos contra TEM8 y su uso
|
ES2845924T3
(es)
|
2013-10-15 |
2021-07-28 |
Scripps Research Inst |
Interruptores de células T con receptores de antígenos quiméricos peptídicos y usos de los mismos
|
CA2926698C
(en)
*
|
2013-10-15 |
2021-06-22 |
The California Institute For Biomedical Research |
Chimeric antigen receptor t cell switches and uses thereof
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
KR20160079854A
(ko)
|
2013-10-31 |
2016-07-06 |
프레드 헛친슨 켄서 리서치 센터 |
변형된 조혈 줄기/선조 및 비-t 효과기 세포 및 이의 용도
|
CA2936501A1
(en)
*
|
2014-01-13 |
2015-07-16 |
Stephen J. Forman |
Chimeric antigen receptors (cars) having mutations in the fc spacer region and methods for their use
|
JP2017507917A
(ja)
|
2014-01-14 |
2017-03-23 |
セレクティスCellectis |
軟骨魚類由来の抗原認識ドメインを使用したキメラ抗原受容体
|
US9694033B2
(en)
|
2014-01-24 |
2017-07-04 |
The Cleveland Clinic Foundation |
IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
|
CN111849912B
(zh)
|
2014-02-14 |
2024-03-15 |
贝里坤制药股份有限公司 |
用诱导型嵌合多肽活化t细胞的方法
|
BR112016018521A2
(pt)
|
2014-02-14 |
2017-10-17 |
Immune Design Corp |
composição, e, kit.
|
WO2015126548A1
(en)
*
|
2014-02-21 |
2015-08-27 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
WO2015127548A1
(en)
|
2014-02-28 |
2015-09-03 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Tc-ptp inhibitors as apc activators for immunotherapy
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
EP3114217A4
(en)
|
2014-03-07 |
2017-09-20 |
Bellicum Pharmaceuticals, Inc. |
Caspase polypeptides having modified activity and uses thereof
|
EP3811970A1
(en)
|
2014-03-15 |
2021-04-28 |
Novartis AG |
Regulatable chimeric antigen receptor
|
HUE054588T2
(hu)
|
2014-04-07 |
2021-09-28 |
Novartis Ag |
Rák kezelése CD19 elleni, kiméra antigénreceptor alkalmazásával
|
US20170029531A1
(en)
|
2014-04-09 |
2017-02-02 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Inhibition of lactate dehydrogenase 5 (ldh-5) binding, incorporation, internalization and/or endocytosis to immune cells
|
CA2945308C
(en)
|
2014-04-10 |
2023-10-31 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Transgene genetic tags and methods of use
|
CA2945388A1
(en)
|
2014-04-23 |
2015-10-29 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
GB2540694A
(en)
|
2014-04-29 |
2017-01-25 |
Seattle Children's Hospital (Dba Seattle Children's Res Institute) |
CCR5 disruption of cells expressing anti-hiv chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
|
US20170210818A1
(en)
|
2014-06-06 |
2017-07-27 |
The California Institute For Biomedical Research |
Constant region antibody fusion proteins and compositions thereof
|
WO2015191874A1
(en)
|
2014-06-12 |
2015-12-17 |
Children's National Medical Center |
Generation of broadly-specific, virus-immune cells targeting multiple hiv antigens for preventive and therapeutic use
|
MY181834A
(en)
|
2014-07-21 |
2021-01-08 |
Novartis Ag |
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
|
CA2955154C
(en)
|
2014-07-21 |
2023-10-31 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
AR101829A1
(es)
|
2014-07-21 |
2017-01-18 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno cll-1
|
PL3177640T3
(pl)
|
2014-08-08 |
2020-11-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Charakteryzujące się wysokim powinowactwem środki terapeutyczne naśladujące PD-11 i sposoby ich wykorzystania
|
WO2016025322A1
(en)
|
2014-08-09 |
2016-02-18 |
Purdue Research Foundation |
Design and development of neurokinin-1 receptor-binding agent delivery conjugates
|
KR20220150428A
(ko)
|
2014-08-12 |
2022-11-10 |
안트로제네시스 코포레이션 |
림프절 b 세포 구역, 피부, 또는 위장관으로 귀소하도록 조작된 car-t 림프구
|
PL3183268T3
(pl)
|
2014-08-19 |
2020-09-07 |
Novartis Ag |
Chimeryczny receptor antygenowy (CAR) anty-CD123 do zastosowania w leczeniu nowotworu złośliwego
|
JP6868554B2
(ja)
|
2014-09-02 |
2021-05-12 |
ベリカム ファーマシューティカルズ, インコーポレイテッド |
MyD88およびCD40ポリペプチドによるキメラ抗原受容体の共刺激
|
IL308324A
(en)
|
2014-09-19 |
2024-01-01 |
Hope City |
IL13RA2-targeted chimeric antigen receptor T cells
|
WO2016054520A2
(en)
|
2014-10-03 |
2016-04-07 |
The California Institute For Biomedical Research |
Engineered cell surface proteins and uses thereof
|
CA2963840A1
(en)
|
2014-10-09 |
2016-04-14 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Long poly(a) plasmids and methods for introduction of long poly(a) sequences into the plasmid
|
CN107106638A
(zh)
|
2014-10-14 |
2017-08-29 |
激流生物科学有限公司 |
具有抗炎特性的肽
|
RU2739794C2
(ru)
|
2014-10-31 |
2020-12-28 |
Массачусетс Инститьют Оф Текнолоджи |
Доставка биомолекул в клетки иммунной системы
|
US20170333480A1
(en)
*
|
2014-11-05 |
2017-11-23 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
CN107002089B
(zh)
|
2014-11-14 |
2021-09-07 |
麻省理工学院 |
化合物和组合物向细胞中的破坏和场实现的递送
|
EP3229810B1
(en)
|
2014-11-17 |
2020-07-22 |
Cellectar Biosciences, Inc. |
Phospholipid ether analogs as cancer-targeting drug vehicles
|
MX2017007272A
(es)
|
2014-12-02 |
2018-06-06 |
Roger Williams Hospital |
Metodos y composiciones para tratar cancer.
|
BR112017011893A2
(pt)
|
2014-12-05 |
2018-07-24 |
City Of Hope |
células t modificadas no receptor de antígeno quimérico direcionado para cs1
|
WO2016100236A2
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled elimination of therapeutic cells
|
WO2016100241A2
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
CA3008162A1
(en)
|
2014-12-15 |
2016-06-23 |
The Regents Of The University Of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
US20190054117A1
(en)
|
2014-12-19 |
2019-02-21 |
Novartis Ag |
Dimerization switches and uses thereof
|
ES2744910T3
(es)
|
2014-12-24 |
2020-02-26 |
Ucl Business Ltd |
Célula
|
IL253149B2
(en)
|
2014-12-29 |
2023-11-01 |
Novartis Ag |
Methods for preparing cells expressing a chimeric receptor antigen
|
KR20170100653A
(ko)
|
2014-12-31 |
2017-09-04 |
안트로제네시스 코포레이션 |
천연 킬러 세포를 사용하여 혈액학적 장애, 고형 종양, 또는 감염 질환을 치료하는 방법
|
US9765330B1
(en)
|
2015-01-09 |
2017-09-19 |
Nant Holdings Ip, Llc |
Compositions and methods for reduction of allograft recognition and rejection
|
IL284985B2
(en)
|
2015-02-18 |
2023-03-01 |
Enlivex Therapeutics R& D Ltd |
Combined immunotherapy and cytokine control therapy for cancer treatment
|
WO2016138034A1
(en)
|
2015-02-24 |
2016-09-01 |
The Regents Of The University Of California |
Binding-triggered transcriptional switches and methods of use thereof
|
SG11201706947TA
(en)
|
2015-03-02 |
2017-09-28 |
Innovative Cellular Therapeutics Co Ltd |
Reducing immune tolerance induced by pd-l1
|
US9777064B2
(en)
|
2015-03-17 |
2017-10-03 |
Chimera Bioengineering, Inc. |
Smart CAR devices, DE CAR polypeptides, side CARs and uses thereof
|
JP2018510652A
(ja)
|
2015-03-18 |
2018-04-19 |
ベイラー カレッジ オブ メディスンBaylor College Of Medicine |
Her2/erbb2キメラ抗原受容体
|
US9717745B2
(en)
|
2015-03-19 |
2017-08-01 |
Zhejiang DTRM Biopharma Co. Ltd. |
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
|
US10800828B2
(en)
|
2015-03-26 |
2020-10-13 |
The Scripps Research Institute |
Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
|
WO2016154628A1
(en)
|
2015-03-26 |
2016-09-29 |
Xiuli Wang |
Bi-specific targeted chimeric antigen receptor t cells
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
WO2016168769A1
(en)
|
2015-04-15 |
2016-10-20 |
The California Institute For Biomedical Research |
Chimeric receptor t cell switches for her2
|
US11091546B2
(en)
|
2015-04-15 |
2021-08-17 |
The Scripps Research Institute |
Optimized PNE-based chimeric receptor T cell switches and uses thereof
|
DK3294764T3
(da)
|
2015-05-15 |
2021-01-25 |
Hope City |
Kimæriske antigenreceptor sammensætninger
|
EP3297664B1
(en)
|
2015-05-19 |
2020-11-18 |
Morphogenesis, Inc. |
Cancer vaccine comprising mrna encoding a m-like-protein
|
IL305621A
(en)
|
2015-05-28 |
2023-11-01 |
Us Health |
Methods for training patients for T-cell therapy
|
AU2016274989A1
(en)
|
2015-06-12 |
2017-11-02 |
Immunomedics, Inc. |
Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
|
US9663756B1
(en)
|
2016-02-25 |
2017-05-30 |
Flodesign Sonics, Inc. |
Acoustic separation of cellular supporting materials from cultured cells
|
WO2016210447A1
(en)
|
2015-06-26 |
2016-12-29 |
University Of Southern California |
Masking chimeric antigen receptor t cells for tumor-specific activation
|
GB201514328D0
(en)
|
2015-08-12 |
2015-09-23 |
Sigmoid Pharma Ltd |
Compositions
|
GB201514874D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Cell
|
GB201514875D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
WO2017035362A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Use of complement pathway inhibitor compounds to mitigate adoptive t-cell therapy associated adverse immune responses
|
SG10201913151TA
(en)
|
2015-09-09 |
2020-03-30 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Genetic engineering of macrophages for immunotherapy
|
US9790467B2
(en)
|
2015-09-22 |
2017-10-17 |
Qt Holdings Corp |
Methods and compositions for activation or expansion of T lymphocytes
|
EP3756682B8
(en)
|
2015-10-05 |
2022-04-27 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
|
RU2759879C2
(ru)
|
2015-10-06 |
2021-11-18 |
Сити Оф Хоуп |
Химерные рецепторы антигена, нацеленные на psca
|
GB201518816D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Receptor
|
GB201518817D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Cell
|
EP3370743A4
(en)
|
2015-11-05 |
2019-04-24 |
City of Hope |
METHODS OF PREPARING LYMPHOCYTES FOR ADOPTIVE TRANSFER THERAPY OF T-CELLS
|
WO2017083274A1
(en)
|
2015-11-09 |
2017-05-18 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Novel rna-based vector system for transient and stable gene expression
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Cxcr2抑制劑
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
EP3390434A2
(en)
|
2015-12-14 |
2018-10-24 |
Bellicum Pharmaceuticals, Inc. |
Dual controls for therapeutic cell activation or elimination
|
US9849092B2
(en)
|
2015-12-21 |
2017-12-26 |
Gholam A. Peyman |
Early cancer detection and enhanced immunotherapy
|
CA3004491A1
(en)
|
2016-01-08 |
2017-07-13 |
The Regents Of The University Of California |
Conditionally active heterodimeric polypeptides and methods of use thereof
|
US9856497B2
(en)
|
2016-01-11 |
2018-01-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Chimeric proteins and methods of regulating gene expression
|
WO2017123548A1
(en)
|
2016-01-14 |
2017-07-20 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Tumor-specific ifna secretion by car t-cells to reprogram the solid tumor microenvironment
|
US20170224733A1
(en)
|
2016-02-05 |
2017-08-10 |
City Of Hope |
Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
|
GB201602563D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
GB201602571D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
EP3416686A1
(en)
|
2016-02-16 |
2018-12-26 |
Dana Farber Cancer Institute, Inc. |
Immunotherapy compositions and methods
|
EP3416690A4
(en)
|
2016-02-19 |
2020-02-19 |
City of Hope |
SPECIFIC APTAMER
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
JP7108551B2
(ja)
|
2016-03-19 |
2022-07-28 |
エクスマ バイオテック コーポレイション |
リンパ球に形質導入を行うための方法及び組成物、並びにその制御された増加
|
EP4015536A1
(en)
|
2016-03-22 |
2022-06-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Early intervention methods to prevent or ameliorate toxicity
|
US20190091308A1
(en)
|
2016-04-08 |
2019-03-28 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
EP3443001A4
(en)
|
2016-04-11 |
2020-04-29 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
KR102522419B1
(ko)
|
2016-06-06 |
2023-04-17 |
시티 오브 호프 |
Baff-r 표적 키메라 항원 수용체-변형된 t 세포 및 그 용도
|
JP7275446B2
(ja)
|
2016-06-06 |
2023-05-18 |
シティ・オブ・ホープ |
Baff-r抗体及びその使用
|
GB201610512D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Chimeric antigen receptor
|
GB201610515D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Cell
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
AU2017295704B2
(en)
|
2016-07-13 |
2023-07-13 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
BR112019002646A2
(pt)
|
2016-08-09 |
2019-10-08 |
Hope City |
composições de poxvírus quimérico e usos das mesmas
|
US9642906B2
(en)
|
2016-09-16 |
2017-05-09 |
Baylor College Of Medicine |
Generation of HPV-specific T-cells
|
US11174306B2
(en)
|
2016-10-19 |
2021-11-16 |
The Scripps Research Institute |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
|
EP3529353A4
(en)
|
2016-10-19 |
2020-05-13 |
City of Hope |
USE OF THE CMV TRIPLEX VACCINE IN T-CARBY LYMPHOCYTE THERAPY
|
WO2018075813A1
(en)
|
2016-10-19 |
2018-04-26 |
City Of Hope |
Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy
|
US10617720B2
(en)
|
2016-10-20 |
2020-04-14 |
Miltenyi Biotech, GmbH |
Chimeric antigen receptor specific for tumor cells
|
WO2018080541A1
(en)
|
2016-10-31 |
2018-05-03 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogennous foxp3 gene
|
US20200095547A1
(en)
|
2016-12-02 |
2020-03-26 |
Darya ALIZADEH |
Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptors
|
AU2017375630B2
(en)
|
2016-12-12 |
2023-12-21 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
|
CN110191955B
(zh)
|
2016-12-13 |
2024-05-31 |
西雅图儿童医院(Dba西雅图儿童研究所) |
在体外和体内对工程化的细胞中表达的化学物质诱导的信号传导复合物进行外源性药物激活的方法
|
EP3336107A1
(en)
|
2016-12-15 |
2018-06-20 |
Miltenyi Biotec GmbH |
Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
|
CN110381989A
(zh)
|
2016-12-21 |
2019-10-25 |
丹麦技术大学 |
用于免疫细胞操作的抗原呈递支架
|
CN110612119A
(zh)
|
2017-02-07 |
2019-12-24 |
西雅图儿童医院(Dba西雅图儿童研究所) |
磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
|
JP7288402B2
(ja)
|
2017-02-17 |
2023-06-07 |
パーデュー・リサーチ・ファウンデーション |
細胞医療用の標的リガンド-ペイロードによる薬剤デリバリー
|
JP7178355B2
(ja)
|
2017-02-28 |
2022-11-25 |
エンドサイト・インコーポレイテッド |
Car t細胞療法のための組成物および方法
|
WO2018165194A1
(en)
|
2017-03-06 |
2018-09-13 |
University Of Washington |
Engineered cells and agent compositions for therapeutic agent delivery and treatments using same
|
US20200405881A1
(en)
|
2017-03-06 |
2020-12-31 |
University Of Washington |
Cell based methods and compositions for therapeutic agent delivery and treatments using same
|
EP3595681A4
(en)
|
2017-03-16 |
2020-12-16 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
TRANSPLANT CELL-BASED IMMUNOTHERAPY FOR LONG-PERIOD ADMINISTRATION OF THERAPEUTIC PROTEIN
|
KR20190131061A
(ko)
|
2017-03-20 |
2019-11-25 |
시티 오브 호프 |
Al 아밀로이드증 치료를 위한 cs1 표적화된 키메라 항원 수용체-변형된 t 세포
|
CN118147137A
(zh)
|
2017-05-17 |
2024-06-07 |
西雅图儿童医院(Dba西雅图儿童研究所) |
生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法
|
WO2019028190A1
(en)
|
2017-08-01 |
2019-02-07 |
City Of Hope |
ANTI-IL1RAP ANTIBODIES
|
WO2019033050A1
(en)
|
2017-08-11 |
2019-02-14 |
City Of Hope |
BISPECIFIC MOLECULE FOR BINDING TO ANTIGEN
|
JP2021512147A
(ja)
|
2018-01-22 |
2021-05-13 |
エンドサイト・インコーポレイテッドEndocyte, Inc. |
Car t細胞の使用方法
|
JP2021512622A
(ja)
|
2018-02-06 |
2021-05-20 |
シアトル チルドレンズ ホスピタル ディー/ビー/エー シアトル チルドレンズ リサーチ インスティテュート |
フルオレセイン結合エーテルリン脂質(fl−ple)で標識された腫瘍に対して最適なt細胞機能を示すフルオレセイン特異的car
|
EP3755366A4
(en)
|
2018-02-23 |
2021-12-29 |
Endocyte, Inc. |
Sequencing method for car t cell therapy
|
EP3775231A2
(en)
|
2018-04-12 |
2021-02-17 |
Umoja Biopharma, Inc. |
Viral vectors and packaging cell lines
|
SG11202007874XA
(en)
|
2018-04-27 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Rapamycin resistant cells
|
EP3833363A4
(en)
|
2018-08-06 |
2022-05-11 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
METHODS AND COMPOSITIONS FOR STIMULATING CHIMERIC ANTIGEN RECEPTOR T-CELLS WITH HAPTEN-TAGGED CELLS
|
AU2019317278A1
(en)
|
2018-08-07 |
2021-03-18 |
Purdue Research Foundation |
Rejuvenation of CAR T cell
|
EP3884058A1
(en)
|
2018-11-21 |
2021-09-29 |
Umoja Biopharma, Inc. |
Multicistronic vector for surface engineering lentiviral particles
|
WO2021007109A1
(en)
|
2019-07-05 |
2021-01-14 |
Purdue Research Foundation |
Design and efficient synthesis of lipid-fluorescein conjugates for car-t cell therapy
|
JP2022548155A
(ja)
|
2019-09-17 |
2022-11-16 |
パーデュー・リサーチ・ファウンデーション |
線維芽細胞活性化タンパク質(fap)を標的とする、がんならびに他の線維性疾患および炎症性疾患の画像化および治療の方法
|
WO2021076788A2
(en)
|
2019-10-16 |
2021-04-22 |
Umoja Biopharma, Inc. |
Retroviral vector for univeral receptor therapy
|
JP2023512071A
(ja)
|
2020-01-30 |
2023-03-23 |
ウモジャ バイオファーマ, インコーポレイテッド |
二特異性形質導入エンハンサー
|
US20230068879A1
(en)
|
2020-02-04 |
2023-03-02 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Anti-dinitrophenol chimeric antigen receptors
|
AU2021216554A1
(en)
|
2020-02-04 |
2022-09-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods and compositions for stimulation of chimeric antigen receptor T cells with hapten labelled cells
|
IL296176A
(en)
|
2020-03-06 |
2022-11-01 |
Purdue Research Foundation |
Methods, compounds and compositions for altering car-t cell activity
|
CN116323656A
(zh)
|
2020-07-16 |
2023-06-23 |
优莫佳生物制药股份有限公司 |
门控衔接子靶向受体
|
CA3199588A1
(en)
|
2020-11-20 |
2022-05-27 |
Andrew Scharenberg |
Vector system for delivery of multiple polynucleotides and uses thereof
|
AU2022212952A1
(en)
|
2021-01-27 |
2023-08-10 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|